The utilisation of nuchal translucency as a prenatal marker of Down syndrome, 1993-1999
| Autor: | James C. Grimwade, Euan M. Wallace, William G Atchison, Paul A Shekleton, Peter Renou, Sheila Mulvey |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Down syndrome
Pediatrics medicine.medical_specialty Referral Victoria Cost-Benefit Analysis Private Practice Ultrasonography Prenatal Fetal anatomy Nuchal translucency Pregnancy medicine Humans Mass Screening Practice Patterns Physicians' Referral and Consultation Mass screening business.industry Ultrasound Obstetrics and Gynecology Reproducibility of Results General Medicine medicine.disease Pregnancy Trimester First Private practice Health Care Surveys Female Down Syndrome business Biomarkers Neck Needs Assessment |
| Zdroj: | The AustralianNew Zealand journal of obstetricsgynaecology. 40(4) |
| ISSN: | 0004-8666 |
| Popis: | A sample of 6,038 obstetric ultrasound referrals and reports between January 1993 and June 1999 in a single Melbourne private ultrasound practice was reviewed to determine whether the referral and reporting pattern for nuchal translucency (NT) measurement has changed. The proportion of both 10-14 week ultrasound scans and mid trimester fetal anatomy scan referrals increased significantly over the study period (p < 0.001 and p < 0.001, respectively). There was also a significant increase in NT reporting and the number of specific referrals for an NT measurement over the study period (p = 0.01 and p < 0.001, respectively). If current trends continue it is likely that the 10-14 week scan for NT measurement will become a routine component of antenatal care. Therefore, as a matter of urgency, it is imperative that the best and most cost-effective screening strategy for Down syndrome in an Australian population is defined. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text